Document Type : Research Paper


Department of Anatomy , College of Medicine, University of Ninevah, Mosul , Iraq


Background and objectives: Amiodarone is an antiarrhythmic medication used to treat abnormal heart rhythms. This study aimed to analyse the histological variations in ovarian follicles of rats after treatment with different doses of amiodarone and evaluate its effects on follicular growth parameters. Methods: Thirty female albino rats were divided into control, therapeutic dose (20 mg/kg), and toxic dose (200 mg/kg) groups. Hormonal analysis showed insignificant changes in the therapeutic group but significant declines in follicle-stimulating hormone, estrogen, and increases in luteinizing hormone and prolactin in the toxic group. Results: Morphometric analysis revealed non-significant changes in primordial and primary follicles across groups but significant declines in secondary and mature follicles in the toxic group compared to the control. Histological examination showed mild variations in the therapeutic group but serious disturbances in ovarian follicular architecture, increased collagen fibres, congestion, inflammation, and corpora lutea hypertrophy in the toxic group. The degenerative effects were dose-related, confirming the safety of a low therapeutic dose. Conclusion: Amiodarone inflicts dose-dependent damage to the ovaries. Doctors can safely prescribe therapeutic doses tailored to patients' medical status.


Main Subjects

  1. Sanchis-Gomar F, Lavie CJ, Morin DP, Perez-Quilis C, Laukkanen JA, Perez MV. Amiodarone in the COVID-19 era: treatment for symptomatic patients only, or drug to prevent infection? American Journal of Cardiovascular Drugs. 2020;20:413-8.
  2. Wang H, Lei F, Bai L, Zhang A. Effects of Amiodarone and Esmolol for Heart Rate and Cardiovascular Changes. Emergency Medicine International. 2022;2022.
  3. Ji Y, Takanari H, Qile M, Nalos L, Houtman MJ, Romunde FL, et al. Class III antiarrhythmic drugs amiodarone and dronedarone impair KIR 2.1 backward trafficking. Journal of Cellular and Molecular Medicine. 2017;21(10):2514-23.
  4. Khataminia M, Najmeddin F, Najafi A, Sharifnia H, Ahmadi A, Sahebnasagh A, et al. Effect of heart rate control with amiodarone infusion on hemodynamic and clinical outcomes in septic shock patients with tachycardia: a prospective, single-arm clinical study. Journal of Pharmaceutical Health Care and Sciences. 2021;7:1-1.
  5. Srinivasan M, Ahmad L, Bhindi R, Allahwala U. Amiodarone in the aged. Australian prescriber. 2019;42(5):158..
  6. Topcu A, Ozturk A, Deniz E, Duman Ozturk S, Arpa M, Atak M. The effects of amiodarone in ovarian injury due to oxidative stress and inflammation caused by ischemia-reperfusion. Immunopharmacology and Immunotoxicology. 2022;44(6):1022-31.
  7. Trohman RG, Sharma PS, McAninch EA, Bianco AC. Amiodarone and thyroid physiology, pathophysiology, diagnosis and management. Trends in cardiovascular medicine. 2019;29(5):285-95.
  8. Fatima N, Mandava K, Khatoon F, Badar J, Begum SF, Narasimhan C, et al. Clinical Profile and side Effects of chronic use of oral Amiodarone in cardiology outpatients department (CLIPSE-A Study)-A prospective observational study. Annals of Medicine and Surgery. 2022;80:104167.
  9. Schrickel JW, Schwab JO, Yang A, Bielik H, Bitzen A, Lüderitz B, Lewalter T. Pro-arrhythmic effects of amiodarone and concomitant rate-control medication. Europace. 2006;8(6):403-7.
  10. Omairi S, Alyodawi K, Al Qaisi T. Histological Changes in Ovary Treated with Dexamethasone and Cefotaxime Sodium. Archives of Razi Institute. 2022;77(3):999.
  11. Silva JF, Ocarino NM, Serakides R. Thyroid hormones and female reproduction. Biology of reproduction. 2018;99(5):907-21.
  12. Polonio AM, Chico-Sordo L, Córdova-Oriz I, Medrano M, García-Velasco JA, Varela E. Focus: Sex & reproduction: Impact of ovarian aging in reproduction: From telomeres and mice models to ovarian rejuvenation. The Yale journal of biology and medicine. 2020;93(4):561.
  13. Broekmans FJ, Knauff EA, te Velde ER, Macklon NS, Fauser BC. Female reproductive ageing: current knowledge and future trends. Trends in Endocrinology & Metabolism. 2007;18(2):58-65.
  14. Djahanbakhch O, Ezzati M, Zosmer A. Reproductive ageing in women. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland. 2007;211(2):219-31.
  15. Sheng JA, Bales NJ, Myers SA, Bautista AI, Roueinfar M, Hale TM, et al. The hypothalamic-pituitary-adrenal axis: development, programming actions of hormones, and maternal-fetal interactions. Frontiers in behavioral neuroscience. 2021;14:256.
  16. Rensen N, Gemke RJ, van Dalen EC, Rotteveel J, Kaspers GJ. Hypothalamic‐pituitary‐adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia. Cochrane Database of Systematic Reviews. 2017(11).
  17. Saadia Z. Follicle stimulating hormone (LH: FSH) ratio in polycystic ovary syndrome (PCOS)-obese vs. non-obese women. Medical Archives. 2020;74(4):289.
  18. Ahmed S, Van Gelder IC, Wiesfeld AC, Van Veldhuisen DJ, Links TP. Determinants and outcome of amiodarone‐associated thyroid dysfunction. Clinical Endocrinology. 2011;75(3):388-94.
  19. Aulia D, Ardiany D. The role of amiodarone in post-operative hypothyroidism patient with factitious thyrotoxicosis and atrial fibrillation: A case report. International Journal of Surgery Case Reports. 2023;106:108252.
  20. Chokesuwattanaskul R, Shah N, Chokesuwattanaskul S, Liu Z, Thakur R. Low-dose amiodarone is safe: a systematic review and meta-analysis. The Journal of innovations in cardiac rhythm management. 2020;11(4):4054.
  21. Sakr SA, Zoil ME, El-Shafey SS. Ameliorative effect of grapefruit juice on amiodarone–induced cytogenetic and testicular damage in albino rats. Asian Pacific Journal of Tropical Biomedicine. 2013;3(7):573-9.
  22. Rasheed R, Arsanyos S. Vitamin E ameliorates the toxic effect of amiodarone on thyroid gland in rats: a histological and ultrastructural study. Journal of Medical Histology. 2018;2(1):57-68.
  23. Özkaya AK, Dilber E, Gürgen SG, Kutlu Ö, Cansu A, Gedik Y. Effects of chronic amiodarone treatment on rat testis. Acta Histochemica. 2016;118(3):271-7.
  24. Al-Shakarchi W, Saber Y, Merkhan M, Mustafa Y. Acute toxicity of coumacines: an in vivo study. Georgian Medical News. 2023; 1(338):126-31.
  25. Al-Shakarchi W, Saber Y, Merkhan MM, Mustafa YF. Sub Chronic Toxicity Study of Coumacines. Pharmacognosy Journal. 2023;15(1).
  26. Meng L, Rijntjes E, Swarts HJ, Keijer J, Teerds KJ. Prolonged hypothyroidism severely reduces ovarian follicular reserve in adult rats. Journal of ovarian research. 2017;10(1):1-8.
  27. Cai SQ, Li Y, Li YA, Wang L, Zhu J, Zhao SH, et al. A rat model of serous borderline ovarian tumors induced by 7, 12-dimethylbenz [a] anthracene. Experimental animals. 2019;68(3):257-65.
  28. Mahmoud SA, Solaiman AA. Light and electron microscopic study of thyroid follicular cells in adult albino rats following green tea administration. Egyptian Journal of Histology. 2014;37(2):417-27.
  29. Jiang LQ, Chen SJ, Xu JJ, Ran Z, Ying W, Zhao SG. Dronedarone and amiodarone induce dyslipidemia and thyroid dysfunction in rats. Cellular Physiology and Biochemistry. 2016;38(6):2311-22.
  30. Hashimoto N, Doki K, Kawano S, Aonuma K, Ieda M, Homma M. Increased serum amiodarone concentration in hypertriglyceridemic patients: Effects of drug distribution to serum lipoproteins. Clinical and Translational Science. 2022;15(3):771-81.
  31. Bognar Z, Fekete K, Bognar R, Szabo A, Vass RA, Sumegi B. Amiodarone’s major metabolite, desethylamiodarone, induces apoptosis in human cervical cancer cells. Canadian journal of physiology and pharmacology. 2018;96(10):1004-11.
  32. Chang YL, Liu ST, Wang YW, Lin WS, Huang SM. Amiodarone promotes cancer cell death through elevated truncated SRSF3 and downregulation of miR-224. Oncotarget. 2018;9(17):13390.
  33. Aguilar M, Rose RA, Takawale A, Nattel S, Reilly S. New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation. Cardiovascular research. 2021;117(7):1645-61.
  34. Krysiak R, Gilowska M, Szkróbka W, Okopień B. The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism. Pharmacological Reports. 2016;68(2):490-4.
  35. Koyyada A, Orsu P. Role of hypothyroidism and associated pathways in pregnancy and infertility: Clinical insights. Tzu-Chi Medical Journal. 2020;32(4):312
  36. Yigit O, Sert TK, Ekinci D, Kirankaya A, Kilinc S. The effect of subclinical hypothyroidism on ovarian volume in prepubertal girls. Northern Clinics of Istanbul Journal. 2023;10:48-52.
  37. Wei S, Gong Z, Guo H, Zhang T, Ma Z. FSH and Equine chorionic gonadotrophin impact follicles development and expression of ovarian FSHR and caspase-9 in mice. Iranian Journal of Veterinary Research. 2017;18(2):79.
  38. Zhou J, Peng X, Mei S. Autophagy in ovarian follicular development and atresia. International journal of biological sciences. 2019;15(4):726.
  39. Shah S, Torres C, Gharaibeh N. Diagnostic Challenges in Ovarian Hyperthecosis: Clinical Presentation with Subdiagnostic Testosterone Levels. Case Reports in Endocrinology. 2022;2022.
  40. Weng J, Chen H, Wu H, Tu M, Wang Z, Chen D, et al. Amiodarone induces epithelial-mesenchymal transition in A549 cells via activation of TGF-β1. Drug and Chemical Toxicology. 2020;43(4):415-22.